BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 15765308)

  • 1. Antiretroviral treatment in correctional facilities.
    Pontali E
    HIV Clin Trials; 2005; 6(1):25-37. PubMed ID: 15765308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Routine HIV Opt-Out Screening and Continuum of Care Services Following Entry into Eight Prison Reception Centers--California, 2012.
    Lucas KD; Eckert V; Behrends CN; Wheeler C; MacGowan RJ; Mohle-Boetani JC
    MMWR Morb Mortal Wkly Rep; 2016 Feb; 65(7):178-81. PubMed ID: 26914322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus in correctional facilities: a review.
    Spaulding A; Stephenson B; Macalino G; Ruby W; Clarke JG; Flanigan TP
    Clin Infect Dis; 2002 Aug; 35(3):305-12. PubMed ID: 12115097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of on-site antiretroviral therapy provision in a South African correctional facility.
    Telisinghe L; Hippner P; Churchyard GJ; Gresak G; Grant AD; Charalambous S; Fielding KL
    Int J STD AIDS; 2016 Nov; 27(13):1153-1161. PubMed ID: 25941052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited spending: an analysis of correctional expenditures on antiretrovirals for HIV-infected prisoners.
    Zaller N; Thurmond P; Rich JD
    Public Health Rep; 2007; 122(1):49-54. PubMed ID: 17236608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-positive in the darkness of a correctional facility: more vulnerable and less treated.
    Huber F; Vandentorren S; Merceron A; Chaponnay A; Gadio G; About V; Pastre A; Nacher M
    Int J STD AIDS; 2019 Apr; 30(5):460-466. PubMed ID: 30630398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nearly one-third of prison inmates aren't gettng proper care.
    AIDS Policy Law; 1999 Oct; 14(20):7. PubMed ID: 11367062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review and meta-analyses on initiation, adherence and outcomes of antiretroviral therapy in incarcerated people.
    Fuge TG; Tsourtos G; Miller ER
    PLoS One; 2020; 15(5):e0233355. PubMed ID: 32421754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpected high rate of wild-type HIV-1 genotype among inmates failing antiretroviral therapy.
    Pontali E; Ventura A; Bruzzone B; Icardi G; Ferrari F
    HIV Clin Trials; 2008; 9(5):341-7. PubMed ID: 18977723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to antiretroviral therapy among HIV-infected prisoners: a systematic review and meta-analysis.
    Uthman OA; Oladimeji O; Nduka C
    AIDS Care; 2017 Apr; 29(4):489-497. PubMed ID: 27582186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates.
    Wohl DA; Stephenson BL; Golin CE; Kiziah CN; Rosen D; Ngo B; Liu H; Kaplan AH
    Clin Infect Dis; 2003 Jun; 36(12):1572-6. PubMed ID: 12802758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Observational study of continuity of HIV care following release from correctional facilities in South Africa.
    Mabuto T; Woznica DM; Lekubu G; Seatlholo N; Mshweshwe-Pakela N; Charalambous S; Hoffmann CJ
    BMC Public Health; 2020 Mar; 20(1):324. PubMed ID: 32164628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to Antiretroviral Therapy and Tuberculosis Treatment in a Prison of Tehran, Iran.
    Seyed Alinaghi SA; Farhoudi B; Mohraz M; Alipour A; Golrokhy R; Hosseini M; Miri J
    Infect Disord Drug Targets; 2016; 16(3):199-203. PubMed ID: 27311561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral prescribing patterns in the Texas prison system.
    Baillargeon J; Borucki MJ; Zepeda S; Jenson HB; Leach CT
    Clin Infect Dis; 2000 Dec; 31(6):1476-81. PubMed ID: 11096015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study of health beliefs and attitudes concerning measures of antiretroviral adherence among prisoners receiving directly observed antiretroviral therapy.
    White BL; Wohl DA; Hays RD; Golin CE; Liu H; Kiziah CN; Simpson G; Kaplan AH
    AIDS Patient Care STDS; 2006 Jun; 20(6):408-17. PubMed ID: 16789854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate.
    Meyer JP; Cepeda J; Wu J; Trestman RL; Altice FL; Springer SA
    JAMA Intern Med; 2014 May; 174(5):721-9. PubMed ID: 24687044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to antiretroviral therapy among HIV-infected prison inmates (Spain).
    Soto Blanco JM; PĂ©rez IR; March JC
    Int J STD AIDS; 2005 Feb; 16(2):133-8. PubMed ID: 15807941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Access to harm reduction and HIV-related treatment services inside Indian prisons: experiences of formerly incarcerated injecting drug users.
    Chakrapani V; Kamei R; Kipgen H; Kh JK
    Int J Prison Health; 2013; 9(2):82-91. PubMed ID: 25758440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Various structural factors influenced early antiretroviral therapy initiation amongst HIV infected prisoners: a qualitative exploration in South Ethiopia.
    Fuge TG; Tsourtos G; Miller ER
    BMC Public Health; 2021 Jul; 21(1):1463. PubMed ID: 34320958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV/AIDS behind bars.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1998 Apr; 4(4):8-13. PubMed ID: 11365184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.